The widely reported cause of Manute Bol's passing was complications from Stevens-Johnson Syndrome (SJS) compounded by acute kidney failure. However, the full context reveals deeper layers to this tragedy.
The Medication Reaction Catalyst
Bol contracted a severe kidney infection while working in South Sudan. During treatment, he developed SJS—a rare, life-threatening skin disorder. Medical investigations concluded this reaction was triggered by medication prescribed for his kidney condition, specifically antibiotics. SJS causes skin blistering, organ damage, and compromised immune function.
Pre-existing Health Vulnerabilities
- Chronic kidney issues requiring frequent dialysis since 2004
- Immune system strain from malaria and prior serious infections
- Extreme physical toll from his 7'7" frame and years of untreated injuries
Systemic Healthcare Failures
Bol's humanitarian work in conflict zones limited consistent medical access. Treatment delays occurred due to visa restrictions when seeking U.S. care. He was hospitalized with kidney failure in May 2010, but SJS developed during subsequent antibiotic administration—a known risk factor missed by medical teams.
The Final Sequence
On June 19, 2010, Bol succumbed to multiple organ failure resulting from SJS progression and kidney shutdown. His case underscores how adverse drug reactions—especially with pre-existing organ compromise—can rapidly escalate fatal complications. The official cause remains SJS/toxic epidermal necrolysis with acute renal failure.
